0 items USD 0.00Search
Your search for "delveinsight tinea versicolor cutaneous mycoses global api manufacturers marketed phase iii 0" gave back 961 results.
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
India is on the verge to witness a major transformation not only in terms of its social stature but in economic repute too. With correct measures...
Catalog:
Enincon
November 2016
Price: USD 2,199.00
India is expected to witness a remarkable rise in healthcare infrastructure in upcoming years. There will there be a dramatic rise in the type and...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
In order to track the upcoming thermal power capacity, enincon consulting llp attempts to provide a competitive project track for all the forthcoming...
Catalog:
Enincon
June 2016
Price: USD 999.00
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions...
Catalog:
NAVADHI
June 2019
Price: USD 1,100.00
The Indian pharma industry has always been a leading industrial sector in the country, with a paralleled dominance of both domestic and foreign...
Catalog:
RNCOS
June 2022
Price: USD 900.00
The business case for captive power plant is growing stronger with the realms of small & mid-size industry clutters mushrooming on pan India...
Catalog:
Enincon
November 2016
Price: USD 2,199.00
India pharmaceutical market was the 11 th largest pharmaceuticals market by value in the world in 2017. It is expected to register second highest...
Catalog:
NAVADHI
April 2019
Price: USD 3,500.00
Trends in the domestic cement demand Tracking cement supply dynamics for Indian market Focusing on regional cement trade and distribution Examining...
Catalog:
Enincon
June 2017
Price: USD 1,099.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
The FY (Fiscal Year) 2015-16 is turning out to be a phenomenal year for the Indian power sector with the record power (Renewable) capacity addition,...
Catalog:
Enincon
December 2016
Price: USD 899.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
